Back to search

Article

microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy

2021-10-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>There is an urgent need for non-invasive, cost-effective biomarkers for Alzheimer’s disease (AD), such as blood-based biomarkers. It is not only to support clinical diagnosis of dementia, but also to allow for timely pharmacological and non-pharmacological interventions evaluation. The aim of this study is to identify and validate a novel blood-based microRNA (m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
70ad0a9d-2bd8-5aba-b5a0-271f70428f03
DOI
10.21203/rs.3.rs-942370/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
microRNA-150-5p: A Novel Blood-Based Biomarker for Alzheimer’s Dementia with Good Correlation to Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral AtrophyDOI 10.21203/rs.3.rs-942370/v1
Select a neighboring publication to make it the new centre.